BoNTs are produced by the anaerobic Clostridium botulinum species of bacteria and are the cause of botulism, a life-threatening neuroparalytic disease. They are extremely potent food poisons, with a mouse LD 50 of 1 ng/kg or less for type A 1, 2 . Contamination of restaurant, catered or commercial foodstuffs or beverages could cause illness in a large number of consumers 1 . Aerosol exposure of BoNTs does not occur naturally, but could be attempted by bioterrorists to achieve a widespread effect. It has been estimated that a single gram of crystalline toxin, evenly dispersed and inhaled, could kill more than one million people 2 .
BoNTs are large proteins with molecular weight of 150 kDa. They are produced by bacteria as a complex, containing the neurotoxin and its associated proteins 3, 4 . They are synthesized as relatively inactive single chain protoxins and are activated by protease nicking to form a dichain molecule (a 50 kDa light chain (LC) and a 100 kDa heavy chain (HC)) linked through a disulfide bond 5 . The HC is responsible for the binding to the target nerve cells (through its C-terminus) and translocating the LC into the cell cytoplasm (through its N-terminus) 6, 7 .
Inside the neuronal cytosol, the LC acts as a Zn This puts a large burden on hospitals, both financially, and in resource management.
Should a bioterror attack occur, there will be a public health crisis due to the lack of effective antidotes against botulism, especially in the absence of reliable presymptomatic diagnostics.
Mass immunization is not feasible or desirable, primarily because BoNT is an effective therapeutic agent against numerous neuromuscular disorders, and also has a wide range of cosmetic applications 20 .
For relief from BoNT-mediated paralysis, it is important that the poisoned nerve cells are rescued through restoration of the neurotransmitter release process. While drugs have been designed to block the endopeptidase activity which is believed to be responsible for the inhibition of neurotransmitter release, delivery of the drugs specifically to the poisoned nerve terminals has remained a major hurdle.
We designed a drug delivery vehicle (DDV) utilizing recombinant BoNT/A heavy chain (rHC), which is known to specifically bind to the presynaptic nerve terminals and be internalized via endocytosis. The DDV construct was a modification of that developed by Goodnough et al. 21 consisting of a targeting molecule, Cy3 labeled rHC, linked by a disulfide bond to a drug stimulant, Oregon green 488 (OG488) labeled 10 kDa dextran.
We attached Mas-7 with the DDV (DDV-Mas-7) (See supplementary figure S1 for details on DDV and DDV-Mas-7 structures) and tested its efficacy in rescuing cultured mouse spinal cord neuronal cells poisoned with BoNT/A (Fig. 1 ). Mas-7 is a wasp venom derived peptide known to be a phospholipase A 2 (PLA 2 ) activator, which effectively stimulated acetylcholine exocytosis in PC12 cells in a SNAP-25 independent manner 22 .
[ 3 H]glycine release assay was used to assess the recovery from BoNT/A poisoning. The experimental design was to mimic a therapeutic application of the DDV strategy to treat 6 individuals poisoned with BoNT/A and exhibiting clinical symptoms of botulism. 23 . It is noteworthy that in BoNT/A poisoned neurons, DDV-Mas-7 treatment had no effect on SNAP-25 cleavage, suggesting that Mas-7 in DDV was effective in rescuing neurons from BoNT/A toxicity via a pathway independent of SNAP-25. To our knowledge, this is the first experimental demonstration of a prospective therapeutic approach to treat botulism in a relevant peripheral neuronal model combined with a feasible targeted drug delivery technology.
For BoNT/A, the widely accepted molecular explanation of its mechanism of action is that toxicity is due to its zinc-dependent endopeptidase activity via proteolysis of SNAP- Second, since the targeted DDV approach is based on the premise of a selective entry of DDV into presynaptic nerve terminals via BoNT/A receptor mediated endocytosis, we demonstrated by competition experiments that the uptake of the DDV-Mas-7 was via
BoNT/A receptors. In these experiments ( BoNT/A was effective as expected with an IC 50 of <1 pM and a total inhibition at ~0.1 nM. However, the rHC was relatively nontoxic at 10 nM or higher (supplementary information Fig. S3 ).
In conclusion, this report provides new knowledge of endocytosis and exocytosis as well as of BoNT trafficking and action. In particular, the results showing the efficacy of DDV-Mas-7 in rescuing neurons from botulism is consistent with our previous reports on a PLA 2 -and RhoB-mediated mechanism of BoNT/A toxicity. In addition, these results suggest an alternative approach towards botulism intervention other than the one commonly emphasized, i.e., protection of vesicle fusion proteins, e.g., SNAP-25 for
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See Supplementary Information for detailed methods. Cy3 was excited at 543 nm line of an argon laser and detected with a 565-nm cutoff filter. 
